Results 141 to 150 of about 4,898,785 (204)

Prion Protein Endoproteolysis: Cleavage Sites, Mechanisms and Connections to Prion Disease. [PDF]

J Neurochem
Castle AR, Westaway D.
europepmc   +1 more source

PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features. [PDF]

J Neurol
Coysh T, Jaunmuktane Z, Hosszu LLP, Majbour N, Zhang F, Campbell T, Darwent L, Matus MB, Chan E, Holm-Mercer L, Mok TH, Wadsworth JDF, Bieschke J, Nithi K, Brandner S, Smith C, Esiri M, Collinge J, Mead S.   +18 more
europepmc   +1 more source

In vivo base editing extends lifespan of a humanized mouse model of prion disease. [PDF]

Nat Med
An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, Pirtle CP, Berríos KN, Newby GA, Yeh WH, Kamath N, Mortberg M, Lian Y, Howard M, DeSouza-Lenz K, Guzman K, Thai A, Graffam S, Laversenne V, Coffey AA, Frei J, Pierce SE, Safar JG, Deverman BE, Minikel EV, Vallabh SM, Liu DR.   +26 more
europepmc   +1 more source

Therapeutic effects of adipose-derived mesenchymal stem cells combined with glymphatic system activation in prion disease. [PDF]

Mol Neurodegener
Zayed M, Kim YC, Jeong BH.
europepmc   +1 more source

Investigating the In Vivo Effects of Anti-Prion Protein Nanobodies on Prion Disease with AAV Vector. [PDF]

Pathogens
Zhang J, Wang M, Wang D, Zhang X, Ma Y, Pardon E, Steyaert J, Abskharon R, Wang F, Ma J.   +9 more
europepmc   +1 more source

Author Correction: In vivo base editing extends lifespan of a humanized mouse model of prion disease. [PDF]

Nat Med
An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, Pirtle CP, Berríos KN, Newby GA, Yeh WH, Kamath N, Mortberg M, Lian Y, Howard M, DeSouza-Lenz K, Guzman K, Thai A, Graffam S, Laversenne V, Coffey AA, Frei J, Pierce SE, Safar JG, Deverman BE, Minikel EV, Vallabh SM, Liu DR.   +26 more
europepmc   +1 more source

Supportive care or exhausted neglect: the role of microglia at the end stage of prion disease. [PDF]

J Clin Invest
Lawson VA.
europepmc   +1 more source

Expression of Concern: Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression. [PDF]

PLoS One
PLOS ONE Editors.
europepmc   +1 more source

Delayed progression of prion disease in mice by polyarginine-facilitated prevention of PrP^Sc propagation in the spleen. [PDF]

Neurotherapeutics
Lee S, Kim J, Lee Y, Yoo M, Kim J, Sohn HJ, Ryou C.   +6 more
europepmc   +1 more source

TREM2 supports neuronal protection and microglial reactivity without an effect on misfolded protein deposition in chronic neurodegenerative prion disease. [PDF]

Front Neurosci
Carpanini SM, Bradford BM, Alfieri A, Piccardo P, Monzón-Sandoval J, Brown D, Boyle A, Pokrovskaya A, Mabbott NA, Manson J, McColl BW.   +10 more
europepmc   +1 more source